Nuk2013 / Shutterstock.com
The Foundation for AIDS Research has warned that the Trans-Pacific Partnership’s (TPP’s) changes to IP policy could restrict access to affordable generic medicines in low and middle income countries.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Trans-Pacific Partnership, amfAR, data exclusivity, generic competition, AIDS
